Redmile Group, LLC Insider Trading $IGMS IGM Biosciences, Inc.
Get free email notifications about insider trading for Redmile Group, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Redmile Group, LLC. Redmile Group, LLC is 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in VAPOTHERM INC ($VAPO) and in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and 10% Owner in Neoleukin Therapeutics, Inc. ($NLTX) and in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in FATE THERAPEUTICS INC ($FATE) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Atreca, Inc. ($BCEL) and 10% Owner in Nurix Therapeutics, Inc. ($NRIX) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Allakos Inc. ($ALLK) and 10% Owner in Stoke Therapeutics, Inc. ($STOK) and Director in Shattuck Labs, Inc. ($STTK) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in PLIANT THERAPEUTICS, INC. ($PLRX) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Gritstone Oncology, Inc. ($GRTS) and 10% Owner in Allovir, Inc. ($ALVR) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Akero Therapeutics, Inc. ($AKRO) and 10% Owner in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in HOOKIPA Pharma Inc. ($HOOK) and 10% Owner in Aprea Therapeutics, Inc. ($APRE) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR).
Redmile Group, LLC in IGM Biosciences, Inc.
Trading Symbol: IGMSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Redmile Group, LLC: Director
Holdings: 3,426,297 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Redmile Group, LLC in IGM Biosciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, ALDR, ALLK, ALVR, FOLD, ANNX, APRE, ARRY, BCEL, BEAM, CABA, FATE, GRTS, HOOK, IGMS, KYMR, NLTX, NRIX, PLRX, RPTX, REPL, STTK, STOK, SYRS, TCRR, VAPO, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 0.00 | 130 | 0 | 3,426,297 | 3.4 M to 3.4 M (0.00 %) |
Jan 05 2021 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 0.00 | 178 | 0 | 3,426,167 | 3.4 M to 3.4 M (+0.01 %) |
Dec 15 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | P | 0.01 | 667,666 | 6,677 | 667,666 | |
Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 51.85 | 8,650 | 448,523 | 3,425,811 | 3.4 M to 3.4 M (+0.25 %) |
Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 52.96 | 14,610 | 773,811 | 3,417,161 | 3.4 M to 3.4 M (+0.43 %) |
Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 49.91 | 47,113 | 2,351,504 | 3,402,551 | 3.4 M to 3.4 M (+1.40 %) |
Sep 09 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 50.28 | 74,433 | 3,742,186 | 3,355,438 | 3.3 M to 3.4 M (+2.27 %) |
Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 48.69 | 74,253 | 3,615,208 | 3,281,005 | 3.2 M to 3.3 M (+2.32 %) |
Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 46.76 | 19,173 | 896,593 | 3,206,752 | 3.2 M to 3.2 M (+0.60 %) |
Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 45.54 | 1,464 | 66,674 | 3,187,579 | 3.2 M to 3.2 M (+0.05 %) |
Sep 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Buy | P | 44.84 | 41,759 | 1,872,327 | 3,186,115 | 3.1 M to 3.2 M (+1.33 %) |
Jul 06 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 0.00 | 178 | 0 | 3,144,356 | 3.1 M to 3.1 M (+0.01 %) |
Apr 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | A | 40.27 | 10,000 | 402,700 | 10,000 | |
Apr 03 2020 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 0.00 | 178 | 0 | 3,144,178 | 3.1 M to 3.1 M (+0.01 %) |
Sep 23 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | C | 0.00 | 1,891,530 | 0 | 1,891,530 | |
Sep 23 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | C | 0.00 | 1,891,530 | 0 | 0 | |
Sep 23 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 16.00 | 3,144,000 | 50,304,000 | 3,144,000 | 0 to 3.1 M |
Sep 23 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | C | 0.00 | 1,891,530 | 0 | 1,891,530 | |
Sep 23 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | C | 0.00 | 1,891,530 | 0 | 0 | |
Sep 23 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Grant | A | 16.00 | 3,144,000 | 50,304,000 | 3,144,000 | 0 to 3.1 M |
Sep 19 2019 | IGMS | IGM Biosciences, I ... | Redmile Group, LLC | Director | Option Exercise | A | 16.00 | 12,100 | 193,600 | 12,100 |
Page: 1